Cargando…

Breast cancer distant recurrence lead time interval by detection method in an institutional cohort

BACKGROUND: Lead time, the interval between screen detection and when a disease would have become clinically evident, has been cited to explain longer survival times in mammography detected breast cancer cases (BC). METHODS: An institutional retrospective cohort study of BC outcomes related to detec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaplan, Henry G., Malmgren, Judith A., Atwood, Mary K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678288/ https://www.ncbi.nlm.nih.gov/pubmed/33218313 http://dx.doi.org/10.1186/s12885-020-07609-3

Ejemplares similares

Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011
por: Malmgren, Judith, et al.
Publicado: (2018)

Increase in mammography detected breast cancer over time at a community based regional cancer center: a longitudinal cohort study 1990–2005
por: Malmgren, Judith A, et al.
Publicado: (2008)

Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010
por: Malmgren, Judith A., et al.
Publicado: (2017)

Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005
por: Kaplan, Henry G, et al.
Publicado: (2011)

Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
por: Malmgren, Judith A., et al.
Publicado: (2019)

Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
por: Kaplan, Henry G., et al.
Publicado: (2022)

Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients
por: Kaplan, Henry G, et al.
Publicado: (2010)

Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval
por: Poodt, Ingrid G. M., et al.
Publicado: (2019)

COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019–2021
por: Malmgren, Judith A., et al.
Publicado: (2023)

Distant recurrence risk following early ipsilateral breast tumor recurrence
por: Ishitobi, Makoto, et al.
Publicado: (2017)

Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
por: Calip, Gregory S., et al.
Publicado: (2022)

Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State March—August 2020
por: Malmgren, Judith, et al.
Publicado: (2021)

Differential Prognostic Indicators for Locoregional Recurrence, Distant Recurrence, and Death of Breast Cancer
por: Chairat, Rungnapa, et al.
Publicado: (2013)

Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
por: Yang, Hai-Yuan, et al.
Publicado: (2017)

Machine Learning-Based Prediction of Distant Recurrence in Invasive Breast Carcinoma Using Clinicopathological Data: A Cross-Institutional Study
por: Sukhadia, Shrey S., et al.
Publicado: (2023)

Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular Subtype
por: Wu, Xingrao, et al.
Publicado: (2016)

Weakly supervised temporal model for prediction of breast cancer distant recurrence
por: Sanyal, Josh, et al.
Publicado: (2021)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
por: Yang, Hai-Yuan, et al.
Publicado: (2018)

Genomic alterations of oligodendrogliomas at distant recurrence
por: Liu, Guanzheng, et al.
Publicado: (2023)

Modeling Interval Timing by Recurrent Neural Nets
por: Raphan, Theodore, et al.
Publicado: (2019)

Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer
por: Park, Hyung Seok, et al.
Publicado: (2012)

Analysis of loco-regional and distant recurrences in breast cancer after conservative surgery
por: Elsayed, Mostafa, et al.
Publicado: (2016)

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer
por: Sparano, Joseph A., et al.
Publicado: (2022)

Time Interval between Self-Detection of Symptoms to Treatment of Breast Cancer
por: Somanna, Shivaraj Nallur, et al.
Publicado: (2020)

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
por: Zhang, Xi, et al.
Publicado: (2023)

Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse
por: Kim, Hee Jun, et al.
Publicado: (2015)

Locoregional and Distant Recurrence Patterns in Young versus Elderly Women Treated for Breast Cancer
por: Rudra, Soumon, et al.
Publicado: (2015)

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
por: Conforti, Fabio, et al.
Publicado: (2019)

A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
por: Murata, Takeshi, et al.
Publicado: (2023)

Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients
por: Lu, Yujie, et al.
Publicado: (2020)

The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients
por: Senft, Asaf, et al.
Publicado: (2016)

Breast screening interval and the characteristics of screen-detected cancers
por: Tupper, Carl A, et al.
Publicado: (2015)

The difference in local, regional and distant breast cancer recurrence between the immediate and delayed DIEP flap procedure; a retrospective cohort study
por: Joosen, M. E. M., et al.
Publicado: (2021)

Local and Distant Recurrence in Resected Sacral Chordomas: A Systematic Review and Pooled Cohort Analysis
por: Kerekes, Daniel, et al.
Publicado: (2018)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

The Impact of Local and Regional Recurrence on Distant Metastasis and Survival in Patients Treated with Breast Conservation Therapy
por: Lee, Jong Seok, et al.
Publicado: (2011)

Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional Recurrence
por: Park, Soojin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_irr92sqdhdj82ighd3au8spnlc